Viibryd and Vraylar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Viibryd (vilazodone hydrochloride) and Vraylar (cariprazine hydrochloride). Common drug interactions include nausea among females and sleep apnoea syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Viibryd and Vraylar. It is created by eHealthMe based on reports of 115 people who take the same drugs from the FDA, and is updated regularly.
What is Viibryd?
Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.
What is Vraylar?
Vraylar has active ingredients of cariprazine hydrochloride. eHealthMe is studying from 6,136 Vraylar users. Check the latest studies of Vraylar.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
115 people who take Viibryd and Vraylar together, and have interactions are studied.
What are the common drug interactions of Viibryd and Vraylar, by gender? *
What are the common drug interactions of Viibryd and Vraylar, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Viibryd and Vraylar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Viibryd and Vraylar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Viibryd:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vraylar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viibryd and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vraylar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on vilazodone hydrochloride and cariprazine hydrochloride (the active ingredients of Viibryd and Vraylar, respectively), and Viibryd and Vraylar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Diphen cause Ileitis Aggravated? - 12 seconds ago
- Could Diphen cause Type Iv Hypersensitivity Reaction? - 13 seconds ago
- Drug interactions of Paracetamol and Thioctic Acid - 13 seconds ago
- Could Nystatin cause Klebsiella Bacteraemia? - 15 seconds ago
- Drug interactions of Revlimid and Famotidine - 16 seconds ago
- Could Acetaminophen And Hydrocodone Bitartrate cause Multiple Sclerosis? - 21 seconds ago
- Could Spironolactone cause Delirium? - 23 seconds ago
- Could Ketoconazole cause Chest X-Ray Abnormal? - 23 seconds ago
- Could Actemra cause Guillain-Barre Syndrome? - 24 seconds ago
- Could Actemra cause Guillain-Barré Syndrome? - 24 seconds ago